| Dr Samer S Hodroge, MD | |
|
1924 Alcoa Hwy, U56, Knoxville, TN 37920-1511 | |
| (865) 305-9340 | |
| (865) 305-8769 |
| Full Name | Dr Samer S Hodroge |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 1924 Alcoa Hwy, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760716971 | NPI | - | NPPES |
| 1529677 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 49053 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians Regional Medical Center | Powell, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Physician Services Pc | 0042307852 | 473 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | Summit Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20071025000571 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | Well-key Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114234382 PECOS PAC ID: 1254528763 Enrollment ID: O20101209001106 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | App Of Tennessee Hm, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396160768 PECOS PAC ID: 5395960694 Enrollment ID: O20140630001088 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Entity Name | Statcare Inpatient Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477086981 PECOS PAC ID: 5496025074 Enrollment ID: O20170714002608 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samer S Hodroge, MD Po Box 440426, Nashville, TN 37244-0426 Ph: (865) 670-6199 | Dr Samer S Hodroge, MD 1924 Alcoa Hwy, U56, Knoxville, TN 37920-1511 Ph: (865) 305-9340 |
News Archive
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Dyax Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's Biologics License Application (BLA) for DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) and has designated the application for Priority Review.
deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.
The New York Times: "More and more, the Great Health Care Debate of 2009 is a numbers game. And the longer the debate goes on, the squishier the numbers seem to get. For months, many leading Democrats, including President Obama, have pushed for the creation of a government-run insurance plan to compete with private insurers. A main argument was that a public plan would save people money. It would not be under pressure to earn profits, pay high private-sector salaries or deny needed care."
› Verified 9 days ago
Daniel Eugene Brewer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Ryan Douglas Kerr, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Landy M Morales, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, Box 56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Sahar M Lotfi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Clayton Devereau Humphrey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Christopher Hill, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Murad Salaita, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 |